Bill Texts: NJ A3668 | 2024-2025 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-02-12 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A3668 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2024-02-13HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey A3668

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey A3668 currently on file.

Social Comments on NJ A3668

feedback